These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 10023694

  • 1. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A.
    Cancer; 1999 Jan 15; 85(2):290-4. PubMed ID: 10023694
    [Abstract] [Full Text] [Related]

  • 2. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.
    Cancer; 1996 Jul 15; 78(2):211-6. PubMed ID: 8673994
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
    Cho BC, Kim JH, Kim CB, Sohn JH, Choi HJ, Lee YC, Ahn JB.
    Oncol Rep; 2006 Mar 15; 15(3):621-7. PubMed ID: 16465422
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
    Wang F, Wang Z, Zhou N, An X, Xu R, He Y, Li Y.
    Am J Clin Oncol; 2011 Aug 15; 34(4):401-5. PubMed ID: 21791984
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of advanced gastric and colorectal cancer with 5-FU, leucovorin and interferon-alpha].
    Tsujimura T, Ezaki K, Ono Y, Nakano H, Kawase K, Iwase K, Hatanaka T, Ohara K, Hobara R, Okamoto M.
    Gan To Kagaku Ryoho; 1993 Mar 15; 20(4):493-8. PubMed ID: 8452387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY, Kwon JH, Kim JH, Song HH, Kim I, Lee KS, Kim HJ, Zang DY, Ahn JS, Lee JA, Park YI.
    Oncol Rep; 2009 Feb 15; 21(2):523-9. PubMed ID: 19148531
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C, Hartmann JT, Lampe CS, Clemens MR, Quietzsch D, Forkmann L, Kanz L.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 Dec 15; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 16. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.
    Elias L, Blumenstein BA, Kish J, Flanigan RC, Wade JL, Lowe BA, Goodwin JW, Crawford ED.
    Cancer; 1996 Sep 01; 78(5):1085-8. PubMed ID: 8780547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.